CRIS Current Research Information System

RICCI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.643
NA - Nord America 2.957
EU - Europa 2.281
SA - Sud America 273
AF - Africa 116
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.900
VN - Vietnam 1.116
SG - Singapore 1.056
IT - Italia 917
CN - Cina 752
HK - Hong Kong 380
GB - Regno Unito 301
BR - Brasile 200
DE - Germania 184
SE - Svezia 167
FR - Francia 139
NL - Olanda 117
RU - Federazione Russa 100
IN - India 89
UA - Ucraina 78
FI - Finlandia 66
BG - Bulgaria 49
IE - Irlanda 49
JP - Giappone 38
ZA - Sudafrica 34
CA - Canada 32
CI - Costa d'Avorio 31
AR - Argentina 27
JO - Giordania 26
ID - Indonesia 24
SC - Seychelles 23
PH - Filippine 22
TH - Thailandia 22
EE - Estonia 20
KR - Corea 20
IQ - Iraq 17
CH - Svizzera 16
PL - Polonia 15
MX - Messico 14
BE - Belgio 13
AU - Australia 12
BD - Bangladesh 12
TG - Togo 12
CO - Colombia 10
EC - Ecuador 10
ES - Italia 10
MY - Malesia 10
PK - Pakistan 10
GR - Grecia 9
SA - Arabia Saudita 9
TR - Turchia 7
TW - Taiwan 7
AT - Austria 6
LT - Lituania 6
CZ - Repubblica Ceca 5
PE - Perù 5
PY - Paraguay 5
VE - Venezuela 5
CL - Cile 4
IR - Iran 4
KE - Kenya 4
NP - Nepal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
TN - Tunisia 3
UY - Uruguay 3
AG - Antigua e Barbuda 2
CG - Congo 2
CR - Costa Rica 2
IL - Israele 2
PT - Portogallo 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
GT - Guatemala 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 9.283
Salva come PNG Salva come JPEG
Città #
Singapore 639
Hong Kong 358
San Jose 341
Ashburn 303
Santa Clara 293
Ho Chi Minh City 286
Hanoi 257
Southend 252
Chandler 179
Fairfield 150
Boardman 130
Beijing 115
Milan 94
Rome 76
Wilmington 74
Bologna 73
Woodbridge 71
Ann Arbor 69
Princeton 69
Seattle 65
Helsinki 62
Houston 57
Dublin 49
Sofia 49
Cambridge 47
New York 46
Jacksonville 45
Los Angeles 45
Dong Ket 44
Da Nang 39
Nanjing 37
Lauterbourg 35
Padova 35
Haiphong 34
Hefei 33
Abidjan 31
Westminster 29
Jinan 28
Tokyo 28
Amman 26
Buffalo 24
Turin 23
Berlin 22
Frankfurt am Main 22
Falkenstein 21
Dallas 19
Hải Dương 19
Shanghai 19
Mountain View 17
Shenyang 17
Biên Hòa 16
Naples 16
Can Tho 15
Florence 15
Guangzhou 15
Saint Petersburg 15
Verona 15
Bari 14
Nanchang 13
Orem 13
Tianjin 13
Chicago 12
Lomé 12
São Paulo 12
Warsaw 12
Brussels 11
Changsha 11
Redondo Beach 11
Sydney 11
Bangkok 10
Chennai 10
Mülheim 10
Phoenix 10
Thái Nguyên 10
Amsterdam 9
Council Bluffs 9
Ha Long 9
San Diego 9
Brescia 8
Catania 8
Denver 8
Fort Worth 8
Montreal 8
Parma 8
San Francisco 8
Seoul 8
Shenzhen 8
Vũng Tàu 8
Zhengzhou 8
Baghdad 7
Bắc Giang 7
London 7
Manchester 7
Ninh Bình 7
Porto Alegre 7
Shijiazhuang 7
Taiyuan 7
Taizhou 7
Tappahannock 7
Toronto 7
Totale 5.399
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 565
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 379
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 317
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 230
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 226
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 223
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 220
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 205
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 199
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 198
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 196
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 191
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 189
Gastroesophageal Reflux Disease and Barrett’s Esophagus 188
Post COVID-19 irritable bowel syndrome 175
Diagnosi dell’infezione da Helicobacter pylori 173
Diagnosi non invasiva e terapia per Helicobacter Pylori 173
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 159
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 156
Peptic ulcer and Helicobacter pylori. 155
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 152
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 148
Probiotici ricombinanti e loro potenziale sulla salute umana 142
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 140
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 139
Recombinant probiotics and their potential in human health 137
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 132
Infezione da Helicobacter pylori: Le nuove indicazioni terapeutiche in Italia 117
Sequential therapy versus Triple Therapy for Helicobacter pylori Eradication: a randomized trial 112
Ruolo della radiologia interventistica nelle complicanze dopo resezione pancreatica 98
Newer agents for Helicobacter pylori eradication 87
null 83
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 77
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 70
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 70
Rifaximin suspension for the eradication of helicobacter pylori 67
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 66
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 65
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 62
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 61
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 60
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 59
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 58
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 57
Rifaximin suspension for the eradication of helicobacter pylori 56
New immunological assays for the diagnosis of Helicobacter pylori infection 56
Review article: The transmission of Helicobacter pylori from stomach to stomach 55
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 55
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 54
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 53
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 52
A new treatment protocol for Helicobacter pylori infection: Preliminary results of a prospective, multicentric and randomized study 51
High eradication rates of Helicobacter pylori with a new sequential treatment 51
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 51
The stool antigen test for detection of Helicobacter pylori after eradication therapy 50
High eradication rates of Helicobacter pylori with a new sequential treatment 50
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 50
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 50
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 50
The stool antigen test for detection of Helicobacter pylori after eradication therapy 49
Review article: The transmission of Helicobacter pylori from stomach to stomach 48
New immunological assays for the diagnosis of Helicobacter pylori infection 47
Helicobacter pylori infection: Anything new should we know? 46
Accurate diagnosis of helicobacter pylori stool tests 45
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 44
Peptic ulcer and Helicobacter pylori 44
A new treatment protocol for Helicobacter pylori infection: Preliminary results of a prospective, multicentric and randomized study 44
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 42
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 41
Helicobacter pylori infection: Anything new should we know? 40
Esophagitis and gastroesophageal reflux 39
Serological response to Helicobacter pylori in gastric and non-gastric cancer 39
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 38
Susceptibility of Helicobacter pylori to Metronidazole 38
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 38
Accurate diagnosis of helicobacter pylori stool tests 38
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 37
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 36
Accuracy of stool antigen test in posteradication assessment of Helicobacter priori infection 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 35
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 35
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy 35
Blood tests in the management of Helicobacter pylori infection 34
Accuracy of stool antigen test in posteradication assessment of Helicobacter priori infection 34
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy 33
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 29
Review article: Diagnosis of Helicobacter pylori infection 29
Blood tests in the management of Helicobacter pylori infection 29
Susceptibility of Helicobacter pylori to Metronidazole 29
Esophagitis and gastroesophageal reflux 29
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 28
Routes of trasmission of Helicobacter pylori infection 28
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 27
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 27
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 27
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 26
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 26
Absence of Helicobacter pylori in dental plaque assessed by stool test [19] 25
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 24
Totale 9.014
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 26 23 80
2021/2022711 94 17 34 74 61 25 9 36 21 22 212 106
2022/2023699 72 97 59 81 30 61 23 34 138 16 56 32
2023/2024717 144 63 49 108 60 110 42 15 18 35 39 34
2024/20252.228 92 246 126 148 541 146 155 100 48 116 41 469
2025/20263.715 452 229 339 293 436 217 300 360 792 297 0 0
Totale 9.459